[{"AccountsPayableCurrent_0_Q2_USD":402400000.0,"LongTermDebtNoncurrent_0_Q2_USD":2925800000.0,"LossContingencyReceivableCurrent_0_Q2_USD":56200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-84400000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-135800000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-82100000.0,"NetIncomeLoss_1_Q2_USD":-57700000.0,"NetIncomeLoss_2_Q2_USD":-19600000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_2_Q2_USD":-87900000.0,"OperatingExpenses_1_Q2_USD":474900000.0,"OperatingExpenses_2_Q2_USD":792000000.0,"OperatingIncomeLoss_1_Q2_USD":-125900000.0,"LongTermDebtCurrent_0_Q2_USD":630100000.0,"OperatingIncomeLoss_2_Q2_USD":-74600000.0,"OperatingLeaseCost_2_Q2_USD":19700000.0,"OperatingLeaseLiability_0_Q2_USD":177500000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":27900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":149600000.0,"OperatingLeasePayments_2_Q2_USD":18200000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":171300000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0271,"OtherAssetsNoncurrent_0_Q2_USD":379100000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":800000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":1500000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":32500000.0,"OperatingLeaseCost_1_Q2_USD":9800000.0,"LitigationReserve_0_Q2_USD":65000000.0,"LineOfCreditFacilityFairValueOfAmountOutstanding_0_Q2_USD":0.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_0_Q2_USD":0.0,"IncreaseDecreaseInOperatingCapital_2_Q2_USD":428200000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-31200000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-1800000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":0.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":6300000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":3791700000.0,"InterestIncomeExpenseNet_1_Q2_USD":-31600000.0,"InterestIncomeExpenseNet_2_Q2_USD":-63600000.0,"InventoryFinishedGoods_0_Q2_USD":607500000.0,"InventoryNet_0_Q2_USD":1115900000.0,"InventoryRawMaterials_0_Q2_USD":267400000.0,"InventoryWorkInProcess_0_Q2_USD":241000000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":205400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":28000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":15700000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":17600000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":20700000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":16500000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":27900000.0,"Liabilities_0_Q2_USD":5719200000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":11230300000.0,"LiabilitiesCurrent_0_Q2_USD":1984500000.0,"LiabilitiesNoncurrent_0_Q2_USD":3734700000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":468300000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-79100000.0,"IncreaseDecreaseInInventories_2_Q2_USD":106000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-1300000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1_Q2_USD":1100000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":400000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":3700000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_2_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":33000000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":64100000.0,"RestructuringCharges_1_Q2_USD":9000000.0,"RestructuringCharges_2_Q2_USD":10700000.0,"RestructuringReserve_0_Q2_USD":10200000.0,"RestructuringReserveSettledWithoutCash2_1_Q2_USD":-100000.0,"RestructuringReserveSettledWithoutCash2_2_Q2_USD":100000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1877700000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":833800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":981100000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":4400000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":34900000.0,"SellingAndMarketingExpense_1_Q2_USD":139800000.0,"SellingAndMarketingExpense_2_Q2_USD":275200000.0,"SeniorNotes_0_Q2_USD":2920200000.0,"ShareBasedCompensation_2_Q2_USD":39100000.0,"StockholdersEquity_0_Q2_USD":5511100000.0,"StockRepurchasedDuringPeriodShares_1_Q2_shares":0.0,"StockRepurchasedDuringPeriodShares_2_Q2_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":133600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":133400000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1991100000.0,"ProductionAndDistributionCosts_2_Q2_USD":45800000.0,"ProductionAndDistributionCosts_1_Q2_USD":24100000.0,"ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess_2_Q2_USD":-5800000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_2_Q2_USD":-1200000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":30400000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-87900000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":554000000.0,"OtherLongTermDebt_0_Q2_USD":53400000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":400000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1900000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":18800000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":-1300000.0,"PaymentsForRestructuring_1_Q2_USD":5100000.0,"PaymentsForRestructuring_2_Q2_USD":9500000.0,"PaymentsOfDividends_2_Q2_USD":65100000.0,"PaymentsOfFinancingCosts_2_Q2_USD":0.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":0.0,"PaymentsToAcquireOtherProductiveAssets_2_Q2_USD":70600000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":68400000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":277300000.0,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":0.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-13500000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":-7300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":133600000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-61100000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-135600000.0,"CommonStockParOrStatedValuePerShare_0_Q2_EUR":0.001,"CommonStockSharesAuthorized_0_Q2_shares":10000000000.0,"CommonStockSharesIssued_0_Q2_shares":133600000.0,"CommonStockValue_0_Q2_USD":7081700000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-27300000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-107500000.0,"ContractWithCustomerAssetGrossCurrent_0_Q2_USD":22400000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":632100000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":1273700000.0,"DebtCurrent_0_Q2_USD":630100000.0,"DebtInstrumentFeeAmount_0_Q2_USD":15600000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.24,"DebtInstrumentUnamortizedDiscountPremiumNet_0_Q2_USD":2100000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":49000000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-25400000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":254900000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":165300000.0,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_1_Q2_USD":0.41,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_2_Q2_USD":0.67,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_1_Q2_USD":0.41,"DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_2_Q2_USD":0.67,"DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_0_Q2_USD":0.0,"DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_0_Q2_USD":18500000.0,"DividendsCommonStockCash_1_Q2_USD":32500000.0,"DebtLongtermAndShorttermCombinedAmount_0_Q2_USD":3555900000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-305500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":317500000.0,"AccountsReceivableNetCurrent_0_Q2_USD":620200000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":9400000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":235500000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":307100000.0,"AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_2_Q2_USD":346100000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":1200000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":13900000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":200000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":7700000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_1_Q2_USD":0.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_2_Q2_USD":0.0,"AllowanceForLoanAndLeaseLossesWriteOffs_1_Q2_USD":600000.0,"AllowanceForLoanAndLeaseLossesWriteOffs_2_Q2_USD":900000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":-1400000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":53400000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":106600000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":0.0,"AssetImpairmentCharges_1_Q2_USD":158600000.0,"AssetImpairmentCharges_2_Q2_USD":158600000.0,"Assets_0_Q2_USD":11230300000.0,"AssetsCurrent_0_Q2_USD":4420200000.0,"AssetsNoncurrent_0_Q2_USD":6810100000.0,"AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":2089300000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":317500000.0,"EarningsPerShareBasic_1_Q2_USD":-0.43,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-32100000.0,"EarningsPerShareBasic_2_Q2_USD":-0.15,"EarningsPerShareDiluted_2_Q2_USD":-0.15,"GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_2_Q2_USD":900000.0,"GainLossOnSaleOfBusiness_2_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":110400000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":237600000.0,"Goodwill_0_Q2_USD":3056800000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-32800000.0,"GoodwillImpairmentLoss_2_Q2_USD":6100000.0,"GoodwillPurchaseAccountingAdjustments_2_Q2_USD":0.0,"GrossProfit_1_Q2_USD":349000000.0,"GrossProfit_2_Q2_USD":717400000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-111900000.0,"GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet_1_Q2_USD":800000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-109100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_2_Q2_USD":-140100000.0,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":-0.84,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":-0.82,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":-0.84,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":-0.82,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_1_Q2_USD":54200000.0,"IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_Q2_USD":89500000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-45200000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-31000000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-22500000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":108200000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1_Q2_USD":-157100000.0,"ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_0_Q2_USD":-8900000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":2313800000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":3785400000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.288,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.221,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-3200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":106200000.0,"FairValueOptionChangesInFairValueGainLoss1_1_Q2_USD":0.0,"FairValueOptionChangesInFairValueGainLoss1_2_Q2_USD":0.0,"FinanceLeaseInterestExpense_1_Q2_USD":200000.0,"FinanceLeaseInterestExpense_2_Q2_USD":400000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":400000.0,"FinanceLeaseLiability_0_Q2_USD":28500000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":5200000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":23300000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":32900000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":5500000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2200000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2400000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3900000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":3000000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":4400000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":2600000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":31000000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":1500000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":3000000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0276,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1471600000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.43,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":133400000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210811"}]